MarketInOut Stock Screener Log In | Sign Up

Genmont Biotech Inc

TAI • Healthcare • Biotechnology • Quote as of 10/30/2026
Genmont Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTAI
Market Capitalization1,466.48 mln
Float80.05 mln

EPS

0.80
Moderate

P / E

21.12
Premium valuation

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.27
Borderline

Relative Strength

82 / 100
Strongly outperforming

Debt / Equity

0.10
Very low leverage

Business Description

Founded in 2000 and headquartered in Tainan City, Taiwan, GenMont Biotech is a life sciences company specializing in beneficial bacteria and gut health solutions. The company develops and produces a wide range of probiotic products in various forms, such as capsules, powders, tablets, and liquids, serving both consumer and industrial markets. GenMont operates across Taiwan, Singapore, China, and other international markets, and also provides custom manufacturing services for third-party brands seeking private-label probiotic products.

Key Fundamentals

EPS0.80
P/E21.12
ROE5.37
RPS4.44
ROIC1.68
ROA4.24
Interest Cover7.32
EBITDA, mln153
EV / EBITDA8.20
EV / EBIT14.74
Revenue, mln382
EV / Revenue3.28

Quote Details

Last 16.90
Change 0 (0%)
Open 16.90
Volume 339,328
Turnover 5,734,643
Average Volume 57,143

Financial Ratios

Pre-Tax Profit Margin21
Leverage Ratio1.28
Current Ratio3.59
Price / Book1.00
Price / Tangible Book1.00
Price / Cash Flow17.00
Price / Free Cash Flow16.72
Debt / Equity0.10
Price / Sales3.74
PEG Ratio7.12

Financial Strength

Altman Z-Score4.23
Piotroski F-Score 6 / 9
Beneish M-Score-2.27
Price to Intrinsic Value1.04
Price to Graham Number0.96
Shiller PE Ratio32.58

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 79 / 100   
1 Month 3.68% 86 / 100   
2 Months 3.68% 72 / 100   
6 Months -4.52% 35 / 100   
1 Year -7.35% 34 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog